Compare CXH & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CXH | XTNT |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.6M | 82.6M |
| IPO Year | N/A | N/A |
| Metric | CXH | XTNT |
|---|---|---|
| Price | $7.94 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 25.9K | ★ 241.7K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.23 | 0.01 |
| Revenue | N/A | ★ $133,083,000.00 |
| Revenue This Year | N/A | $15.95 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $33.35 | $62.97 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $6.41 | $0.33 |
| 52 Week High | $7.74 | $0.95 |
| Indicator | CXH | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.86 | 54.22 |
| Support Level | $7.92 | $0.59 |
| Resistance Level | $8.00 | $0.66 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 16.67 | 94.53 |
Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.